March 21, 2008
Noven down on delay of reports
Topix SEC News
Noven Pharmaceuticals stock fell to a new 52-week low Thursday after the company released early fourth quarter and full-year results, and said it was delaying full results. via South Florida Business Journal
Read full story
For All of your GOING PUBLIC needs contact Artfield Investments (www.ArtfieldInvestments.com)
Filed under SEC News by
Leave a Comment
You must be logged in to comment